L40 L20
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosis of atopic dermatitis or diagnosis of psoriasis
Exclusion criteria
Exclusion criteria: No inclusion of patients who, in the opinion of the enrolling physician, are unable to complete the questionnaires accurately and truthfully. No inclusion of individuals dependent on the sponsor, study director, or responsible physician. Individuals who are unable to provide consent are excluded from participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference (performance improvement) in cardiorespiratory fitness measured by the steep ramp test (using a cycle ergometer) on days 1 and 21 of dermatological rehabilitation. | — |
Secondary
| Measure | Time frame |
|---|---|
| ESC SCORE2/SCORE2-OP, blood pressure, pulse, weight, BMI, waist circumference, fasting blood glucose, laboratory parameters: triglycerides, total cholesterol, LDL, HDL, GOT, GPT, GGT, HbA1c, vitamin D, alkaline phosphatase, bilirubin, creatinine, GFR, NT-proBNP, hsCRP, neopterin, lipoprotein (a), IL-6, uric acid. DLQI (Quality of Life), PASI (Disease Activity of Psoriasis) / EASI (Disease Activity of Atopic Dermatitis) / SCORAD (disease activity of atopic dermatitis), Patient's Global Assessment of Psoriasis (patient’s own assessment of psoriasis disease activity) / Patient's Global Assessment of Atopic Dermatitis (patient’s own assessment of atopic dermatitis disease activity), NRS for pruritus (mean and maximum), subjective treatment success, satisfaction with therapeutic options in rehabilitation. | — |
Countries
Germany
Contacts
Fachklinik Bad Bentheim